Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
Carl Icahn. Photo by: Adam Jeffery/CNBC/NBCU Photo Bank via Getty Images.
Activist investor Carl Icahn is seeking to block the $67 billion merger between health insurer Cigna and pharmacy benefit giant Express Scripts, according to The Wall Street Journal.
- Icahn has not previously disclosed a stake in either company, but now apparently has taken a "sizable" position in Cigna (although it's still below 5%).
Our thought bubble: Some analysts were scratching their heads over the deal, which was viewed as a rushed attempt to copy UnitedHealth Group — and generally questionable given that Express Scripts would lose its most lucrative client in Anthem. Icahn's stake, plus the pending federal antitrust reviews, really do put this deal in jeopardy.